Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA supplement subcommittee

This article was originally published in The Tan Sheet

Executive Summary

Meeting scheduled for March 25 will evaluate "recognized scientific principles that would facilitate reaching a conclusion as to whether a particular substance is a 'metabolite' of another substance that is a 'dietary ingredient' defined in the [FD&C Act] and, therefore, is itself a dietary ingredient," according to March 5 Federal Register notice. FDA says the act currently "is to what substances are, or are not, metabolites of other substances," which makes it "often difficult to determine whether a particular substance...can be marketed as [a] dietary supplement." Meeting will be held at Holiday Inn, 10,000 Baltimore Ave., College Park, Md. Dietary Supplement Subcommittee of the Food Advisory Committee will not meet March 27-28, as reported in 1"The Tan Sheet" Feb. 10, 2003, In Brief...

Related Content

“Metabolite” DSHEA Definition Incorporates Oral Ingestion
NDAC meetings rescheduled





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts